Exchange: NASDAQ·Updated 07:59 PM EDT

ILMN News

News
all
press releases
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026PR NewswireSAN DIEGO, Oct. 8, 2026SAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that...
PR Newswire
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026PR NewswireSAN DIEGO, Oct. 8, 2026SAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that...
PR Newswire
More News
Illumina releases SpliceAI2 to help advance rare disease research
Illumina releases SpliceAI2 to help advance rare disease research Illumina releases SpliceAI2 to help advance rare disease researchPR NewswireSAN DIEGO, Oct. 8, 2026In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing...
PR Newswire
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
Illumina (NASDAQ: ILMN) is building a deeper AI strategy around the biological data created by its sequencing technology. The Billion Cell Atlas, expanding drugmaker partnerships, and improving core business could create a new growth engine if Illumina can turn its scientific adv...
Nasdaq News: Markets
REGN or ILMN: Which Is the Better Value Stock Right Now?
REGN vs. ILMN: Which Stock Is the Better Value Option?
Zacks
Is the Options Market Predicting a Spike in Illumina Stock?
Investors need to pay close attention to ILMN stock based on the movements in the options market lately.
Zacks
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outlook despite China headwinds.
Zacks
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 5.48% on an annualized basis producing an average annual return of 14.65%. Currently, Illumina has a market capitalization of $37.84 billion.read more...
Benzinga
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.
Zacks
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Here is how Brookdale Senior Living (BKD) and Illumina (ILMN) have performed compared to their sector so far this year.
Zacks
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.read more...
Benzinga

Advertisement|Remove ads.